Lifestyle Delivery Systems Inc. Announces CSPA Group Filling the Second Order of Rêveur Live Resin for Rise Distribution
VANCOUVER, British Columbia, March 18, 2019 /CNW/ -- Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") announces that its subsidiary, CSPA Group, Inc. ("CSPA"), has delivered its second large batch of Rêveur live resin to Rise Distribution ("Rise"). Simultaneously with the second batch delivery, Rise has placed Rêveur in five new stores bringing the total to 20 stores.
CSPA has received a purchase order from Rise Distribution for five more strains of Rêveur live resin product. The Rêveur live resin has successfully passed California State testing and all new packaging compliance regulations. CSPA Group successfully delivered the new batch of Rêveur to Rise Distribution on March 13th 2019. Rise Distribution will quickly restock Rêveur into dispensaries ensuring that customers have continued access to Rêveur products. Below is the complete list of stores retailing Rêveur live resin with recently added stores noted in bold;
- All About Wellness
- Bay Care Delivery
- Bloom Room SF
- Cannabis Buyers' Club of Berkeley
- Diamond Bonsai
- Exhale Med Center
- Fire Farms
- Ganja Goddess Dist.
- Green Pearl
- High Note West (Culver City)
- Higher Elevation
- Home Grown Holistic Collective
- Hometown Heart Oakland (TSM)
- Humboldt Patient Resource Center
- Leef Industries
- Life Enhancement Services
- Los Angeles Valley Caregivers
- March and Ash
Casey Fenwick, President of LDS, stated,
The fact that Rise has a need for the second batch of Rêveur product so quickly shows the product has a demand. Also, CSPA demonstrates that it has a repeatable process by providing completely different strains, again being able to pass California's strict testing requirements and comply with the new packaging laws. CSPA and its process for manufacturing Rêveur can continually supply California's growing recreational market.
The Company's CEO, Brad Eckenweiler, stated,
We knew that Rêveur live resin would be a great product because of where we sourced the starting material coupled with the state-of-the-art facility we have built over the last three years. Rêveur's success is a product of the hard work the Company and its licensed subsidiaries have put in. Making sure its operating subsidiaries have all necessary state/local licensing, as well as the time spent completing a facility capable of making a product people repeatedly purchase. With the new ability to grow our own starting material from seed, extract it, and deliver it straight to consumers' homes, we are excited for the future of the brand and the Company.
About CSPA Group, Inc.
CSPA Group, Inc. is located in Adelanto, California and is a City-permitted and State-Licensed manufacturer and distributor/transporter in the California cannabis industry. Manufacturing extracted oils and distillates, and producing CannaStripsTM under a license agreement with Lifestyle Delivery Systems Inc. a British Columbia corporation.
Lifestyle Delivery Systems Inc. is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. The Company's technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to other forms of delivery but also superior bioavailability of cannabis constituents. Some strips will also include supplemental co-active ingredients such as nutraceuticals, vitamins and peptides. The technology provides a new way to accurately meter the dosage and assure the purity of selected product. From start to finish, the production process, based on the Company's technology, tests for quality and composition of all the ingredients used in each and every strip which results in a delivery system that is safe, consistent and effective.
Lifestyle Delivery Systems Inc.
CEO & Director
FOR MORE INFORMATION, PLEASE CONTACT:
Cautionary Disclaimer Statement:
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.